New hope for tough bladder cancers: Final-Stage trial tests promising drug
NCT ID NCT06857175
Summary
This large, late-stage trial is testing whether a new drug called BL-B01D1 works better than standard chemotherapy for people with advanced bladder cancer that has come back or spread. It is for patients whose cancer has continued to grow despite receiving two common types of treatment first. Researchers will randomly assign about 508 participants to receive either the new drug or a chemotherapy chosen by their doctor to compare survival and side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, Shanghai Municipality, China
Contact
Conditions
Explore the condition pages connected to this study.